Tomer Mark

5PUBLICATIONS
20CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Pharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 22, 2022
Overall Survival With Daratumumab, Bortezomib, and Dexamethasone in Previously Treated Multiple Myeloma (CASTOR): A Randomized, Open-Label, Phase III Trial.

Pieter Sonneveld, Asher Chanan-Khan, Katja Weisel

|Nov 17, 2021
Real-world outcomes of pomalidomide therapy after lenalidomide induction in relapsed/refractory multiple myeloma.

Tomer Mark, Angelica Falkenstein, Jonathan Kish

|Feb 12, 2019
Phase II study of carfilzomib and dexamethasone therapy for newly diagnosed multiple myeloma.

Peter A Forsberg, Adriana C Rossi, Angelique Boyer

Pageof 1